# Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tumour-necrosis-factor-antagonist-use-and-associated-risk-reduction-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jeffrey D. Greenberg,Joel M. Kremer,Jeffrey R. Curtis,Marc C. Hochberg,George Reed,Peter Tsao,Michael E. Farkouh,Adeel Nasir,Soko Setoguchi,Daniel H. Solomon |
| Citations | 350 |
| DOI | 10.1136/ard.2010.129916 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ard.bmj.com/content/annrheumdis/70/4/576.full.pdf |
| OpenAlex ID | https://openalex.org/W2096809109 |
| PMID | 21109516 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Soko Setoguchi](https://scholariq.org/researchers/soko-setoguchi/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Streptococcal Infections and Treatments](https://scholariq.org/topics/streptococcal-infections-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.